Thursday, April 11, 2013

Comparative Effectiveness Research Series ~ online training

News &
PublicationsMeetings & TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting
AdvertisingCareer left
Purchase two of the following online courses in one transaction and save 10%. Purchase all three in one transaction and save 20%. Discount will be reflected in the final step of the checkout process.
In 90 minutes, you will get a combination of background instruction into the principals of CER, current and future impact on the broader regulatory industry, along with implications for future communications, marketing, monitoring, and resource planning. Real-world examples will be used to help explain changing implications of new sources of data and outcomes measures, detailing the transition to newer CER based advertising and promotional material and how to effectively incorporate these into developing corporate sales and marketing, value research, and product attribute messaging.
Faculty:
Danny A. Benau, PhD, Director, Biomedical Writing Programs, University of the Sciences
Darshan Kulkarni, JD, PharmD, MS, Principal Attorney, The Kulkarni Law Firm
Andrew M. Peterson, PharmD, PhD, Dean, Mayes College, University of the Sciences
Understand changes to today’s practices, when and why they are being transitioned to the newer CER format, and methods to effectively include these changes into future studies, payor and patient interactions and value focused research.
Faculty:
Danny A. Benau, PhD, Director, Biomedical Writing Programs, University of the Sciences
Stephanie Michelle Knight, Associate Director, Pfizer Inc.
Andrew M. Peterson, PharmD, PhD, Dean, Mayes College, University of the Sciences
This 90-minute online offering will allow you to quickly understand current practices, when and why they are being transitioned to the newer CER format, and methods to effectively include these changes into your future investigations.
Faculty:
Danny A. Benau, PhD, Director, Biomedical Writing Programs, University of the Sciences
Darshan Kulkarni, JD, PharmD, MS, Principal Attorney, The Kulkarni Law Firm
 


Newly Released Webinar:
All transfers of value to covered recipients must be tracked by covered manufacturers starting August 1. This 90-minute webinar will provide a high-level overview of the basic requirements of the final rule for implementing the Physicians Payment Sunshine Act, before turning to many of the gray areas where manufacturers are struggling to understand what they need to track and report. This webinar will focus on the requirements for research-related activities, indirect payments, and the determination of value for many educational efforts. Industry experts will help you go beyond a cursory understanding of the rule to help their organizations determine how they will ensure compliance and avoid the costly fines.
April 9, 11, 16 & 18
12:00-1:30PM ET
April 10
12:00-1:30PM ET
April 25-26
10:00-11:30AM ET

No comments:

Post a Comment